Form 8-K
8-K — EDAP TMS SA
Accession: 0001171843-26-003773
Filed: 2026-05-29
Period: 2026-05-29
CIK: 0001041934
SIC: 3845 (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS)
Item: Other Events
Documents
8-K — f8k_052926.htm (Primary)
EX-99.1 — EXHIBIT 99.1 (exh_991.htm)
XML — IDEA: XBRL DOCUMENT (R1.htm)
8-K — FORM 8-K
8-K (Primary)
Filename: f8k_052926.htm · Sequence: 1
false
0001041934
0001041934
2026-05-29
2026-05-29
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 29, 2026
EDAP TMS SA
(Exact name of Registrant as specified in its charter)
France
000-29374
98-1644844
(State or other jurisdiction of incorporation)
(Commission File No.)
(I.R.S. Employer Identification No.)
Parc d’Activites la Poudrette-Lamartine
4/6, rue du Dauphiné
Vaulx-en-Velin, France 69120
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (+33)
47-215-3150
Not Applicable
(Former name or former address if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
______________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Trading Symbol(s)
Name of Each Exchange on Which Registered
American Depositary Shares, each representing one Ordinary Share
(Ordinary Shares, nominal value €0.13 per share)
EDAP
NASDAQ Global Market
Indicated by check mark whether the registrant is an emerging growth company as defined in Rule 405
of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of
this chapter).
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events.
On May 29, 2026, EDAP TMS S.A. (the “Company”)
issued a press release announcing that it will begin operating under the new corporate name “FocalTherics” and that its American
Depositary Shares (“ADS”), each representing one Ordinary Share (Ordinary Shares, nominal value €0.13 per share), will
begin trading under the new ticker symbol “FOCL” on the Nasdaq Global Market at the market open on June 1, 2026. The Company’s
legal name will remain EDAP TMS S.A., and the Company intends to seek shareholder approval for a corresponding legal name change at a
future general meeting of shareholders. The CUSIP number for the ADSs will remain unchanged, and shareholders are not required to take
any action in connection with the corporate name or ticker symbol change.
In addition, the Company announced its intention to
report and classify its Extracorporeal Shock Wave Lithotripsy (“ESWL”) and Distribution operating segments as discontinued
operations in the Company’s financial statements beginning with the Company’s second quarter 2026 financial results.
The Company will discuss its new corporate identity,
growth strategy, and business outlook at its Investor Day on June 1, 2026 at 8:00 a.m. ET and invites participants to join the event via
the Events and Presentations section of the Company’s Investor Relations website. A replay of the webcast and associated slide presentation
will be available on the Company’s website.
A copy of the press release is attached hereto as Exhibit
99.1 and is incorporated by reference herein.
Exhibit No.
Description
99.1
Press Release dated May 29, 2026
104
Cover Page Interactive Data File-the cover page XBRL tags are embedded within the Inline XBRL document
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: May 29, 2026
EDAP TMS S.A.
By:
/s/ Sanket Shah
Sanket Shah
General Counsel and Corporate Secretary
EX-99.1 — EXHIBIT 99.1
EX-99.1
Filename: exh_991.htm · Sequence: 2
Exhibit 99.1
EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive
Focus on High-Growth Robotic Focal Therapy
· Company will Begin Trading Under New Ticker Symbol “FOCL” at Market Open on June 1, 2026
· Company Intends to Report and Classify its Legacy Non-Core ESWL and Distribution Operating Segments as Discontinued Operations
Beginning with Second Quarter 2026 Financial Results
· Investor Day to be Held on June 1, 2026 to Highlight Company Vision and Long-Term Strategy under New FocalTherics Corporate Identity
AUSTIN, Texas, May 29, 2026 - EDAP TMS S.A. (Nasdaq: EDAP) (the “Company”),
the global leader in robotic energy-based therapies, today announced that it will operate under the new corporate name “FocalTherics”
to reflect its exclusive and strategic focus on high-growth robotic focal therapy. The Company also announced its intention to report
and classify its Extracorporeal Shock Wave Lithotripsy (“ESWL”) and Distribution operating segments as discontinued operations
in the Company’s financial statements beginning with second quarter 2026 financial results. In conjunction with this defined focus,
the Company is changing its ticker symbol on Nasdaq from “EDAP” to “FOCL”, effective at market open on June
1, 2026.
“FocalTherics is derived from the words ‘Focal Therapy’
and ‘Therapeutics’.” said Ryan Rhodes, Chief Executive Officer. “This new name and identity reflects and reinforces
the Company’s emerging leadership in defining, building and driving the growing category of robotic focal therapy. Additionally,
our new corporate identity aligns directly with our flagship market leading product brand, Focal One®.”
Rhodes added, “Together, the new corporate name and ticker symbol
will create a stronger connection between our company identity, our strategic product brand and the significant opportunity ahead. These
combined updates are designed to strengthen how investors, analysts, and stakeholders understand our vision, recognize the momentum of
our HIFU business, and appreciate our growing leadership position in Robotic Focal Therapy.”
The ticker symbol change will apply to the Company’s American
Depositary Shares, each representing one Ordinary Share (Ordinary Shares, nominal value €0.13 per share). The Company’s legal
name will remain EDAP TMS S.A., and the Company intends to submit a corresponding change of legal name for shareholder approval at a future
general meeting of the Company’s shareholders. No action is required by shareholders with respect to the name change or ticker symbol
change announced today, and these changes will not affect the existing rights of shareholders. Following the ticker symbol change, the
American Depositary Shares will continue to be listed on Nasdaq and the CUSIP number will remain unchanged.
The Company will discuss its new corporate identity, growth strategy,
and business outlook at the Investor Day scheduled on June 1, 2026 at 8:00 am ET and invites participants to join the event via the Events
and Presentations section of the Investor Relations website. A replay of the webcast and associated slide presentation will be available
on the Company’s website.
About FocalTherics
A recognized global leader in Robotic Focal Therapy,
FocalTherics develops, manufactures, and markets minimally invasive medical devices worldwide to treat various conditions using proprietary
focused ultrasound technology. The Company’s flagship platform, Focal One Robotic HIFU, combines advanced imaging, real-time treatment
planning, robotic precision, and HIFU technology to deliver personalized focal therapy designed to optimize clinical outcomes while preserving
quality of life. FocalTherics is committed to expanding the clinical adoption of its patented focused ultrasound-based robotic therapy
platforms through continued innovation, clinical evidence generation, physician education, and global market development initiatives.
For more information about FocalTherics, visit FocalTherics.com.
Forward-Looking Statements
In addition to historical information, this press release contains forward-looking
statements within the meaning of applicable federal securities laws, including Section 27A of the U.S. Securities Act of 1933 (the “Securities
Act”) or Section 21E of the U.S. Securities Exchange Act of 1934, which may be identified by words such as “believe,”
“can,” “contemplate,” “could,” “plan,” “intend,” “is designed to,”
“may,” “might,” “potential,” “objective,” “target,” “project,”
“predict,” “forecast,” “ambition,” “guideline,” “should,” “will,”
“estimate,” “expect” and “anticipate,” or the negative of these and similar expressions, which reflect
our views about future events and financial performance. Such statements are based on management's current expectations and are subject
to a number of risks and uncertainties, including matters not yet known to us or not currently considered material by us, and there can
be no assurance that anticipated events will occur or that the objectives set out will actually be achieved. Important factors that could
cause actual results to differ materially from the results anticipated in the forward-looking statements include, among others, the clinical
status and market acceptance of our High Intensity Focused Ultrasound (“HIFU”) devices, risks associated with the intended
discontinuation of the Company's ESWL and Distribution operating segments, including that the discontinuation may take longer or cost
more than expected, may result in disputes with customers, distributors, employees or other counterparties, and may not produce the strategic
benefits anticipated as well as risks associated with the current worldwide inflationary environment, the uncertain worldwide economic,
political and financial environment, geopolitical instability, climate change and pandemics, or other public health crises, and their
related impact on our business operations, including their impacts across our businesses or demand for our devices and services.
Other factors that may cause such a difference may also include, but are
not limited to, those described in the Company's filings with the Securities and Exchange Commission and in particular, in the sections
"Cautionary Statement on Forward-Looking Information" and "Risk Factors" in the Company's Annual Report on Form 10-K.
Forward-looking statements speak only as of the date they are made. Other
than required by law, we do not undertake any obligation to update them in light of new information or future developments. These forward-looking
statements are based upon information, assumptions and estimates available to us as of the date of this press release, and while we believe
such information forms a reasonable basis for such statements, such information may be limited or incomplete.
Investor Contact
Louisa Smith
Gilmartin Group
investor.relations@focalone.com
XML — IDEA: XBRL DOCUMENT
XML
Filename: R1.htm · Sequence: 7
v3.26.1
Cover
May 29, 2026
Cover [Abstract]
Document Type
8-K
Amendment Flag
false
Document Period End Date
May 29, 2026
Entity File Number
000-29374
Entity Registrant Name
EDAP TMS SA
Entity Central Index Key
0001041934
Entity Tax Identification Number
98-1644844
Entity Incorporation, State or Country Code
I0
Entity Address, Address Line One
Parc d’Activites la Poudrette-Lamartine
Entity Address, Address Line Two
4/6
Entity Address, Address Line Three
rue du Dauphiné
Entity Address, City or Town
Vaulx-en-Velin
Entity Address, Country
FR
Entity Address, Postal Zip Code
69120
City Area Code
(+33)
Local Phone Number
47-215-3150
Written Communications
false
Soliciting Material
false
Pre-commencement Tender Offer
false
Pre-commencement Issuer Tender Offer
false
Title of 12(b) Security
American Depositary Shares, each representing one Ordinary Share
(Ordinary Shares, nominal value €0.13 per share)
Trading Symbol
EDAP
Security Exchange Name
NASDAQ
Entity Emerging Growth Company
false
X
- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details
Name:
dei_AmendmentFlag
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Area code of city
+ References
No definition available.
+ Details
Name:
dei_CityAreaCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Cover page.
+ References
No definition available.
+ Details
Name:
dei_CoverAbstract
Namespace Prefix:
dei_
Data Type:
xbrli:stringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details
Name:
dei_DocumentPeriodEndDate
Namespace Prefix:
dei_
Data Type:
xbrli:dateItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details
Name:
dei_DocumentType
Namespace Prefix:
dei_
Data Type:
dei:submissionTypeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine1
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine2
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Address Line 3 such as an Office Park
+ References
No definition available.
+ Details
Name:
dei_EntityAddressAddressLine3
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the City or Town
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCityOrTown
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
ISO 3166-1 alpha-2 country code.
+ References
No definition available.
+ Details
Name:
dei_EntityAddressCountry
Namespace Prefix:
dei_
Data Type:
dei:countryCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details
Name:
dei_EntityAddressPostalZipCode
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityCentralIndexKey
Namespace Prefix:
dei_
Data Type:
dei:centralIndexKeyItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityEmergingGrowthCompany
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details
Name:
dei_EntityFileNumber
Namespace Prefix:
dei_
Data Type:
dei:fileNumberItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details
Name:
dei_EntityIncorporationStateCountryCode
Namespace Prefix:
dei_
Data Type:
dei:edgarStateCountryItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityRegistrantName
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details
Name:
dei_EntityTaxIdentificationNumber
Namespace Prefix:
dei_
Data Type:
dei:employerIdItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Local phone number for entity.
+ References
No definition available.
+ Details
Name:
dei_LocalPhoneNumber
Namespace Prefix:
dei_
Data Type:
xbrli:normalizedStringItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details
Name:
dei_PreCommencementIssuerTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details
Name:
dei_PreCommencementTenderOffer
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details
Name:
dei_Security12bTitle
Namespace Prefix:
dei_
Data Type:
dei:securityTitleItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details
Name:
dei_SecurityExchangeName
Namespace Prefix:
dei_
Data Type:
dei:edgarExchangeCodeItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14a
-Subsection 12
+ Details
Name:
dei_SolicitingMaterial
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details
Name:
dei_TradingSymbol
Namespace Prefix:
dei_
Data Type:
dei:tradingSymbolItemType
Balance Type:
na
Period Type:
duration
X
- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details
Name:
dei_WrittenCommunications
Namespace Prefix:
dei_
Data Type:
xbrli:booleanItemType
Balance Type:
na
Period Type:
duration